Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...

Purpose: The association of antipsychotic and antidepressant drugs with Q-T interval prolongation is reviewed. Summary: Prolongation of the Q-T interval can be of particular concern to ...

last week approved Bristol Myers Squibb’s antipsychotic drug Cobenfy (xanomeline and trospium chloride), the first ...

On 26 September 2024, Cobenfy (KarXT) gained US Food and Drug Administration (FDA ... and its novel mode of action (MoA) could spark further interest in the development of non-dopaminergic ...

Most schizophrenia medications, broadly known as antipsychotics ... and that a different mechanism of action holds hope for ...

Karuna Therapeutics said this morning that the FDA has formally started its review of KarXT, aiming to become the first drug to reach the market for schizophrenia with a new mechanism of action in ...